Are there any ongoing research or future prospects?
Research into MPS is ongoing, with several promising avenues being explored:
- Gene therapy aims to correct the underlying genetic defect by delivering a functional copy of the gene to the patient's cells. - Substrate reduction therapy focuses on reducing the production of GAGs to decrease their accumulation. - New enzyme replacement therapies and delivery methods are being developed to improve efficacy and reduce side effects.
